Results
|
|
1.
|
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease. MedStar authors:
Year: 2017
Citation: - Journal of Alzheimer's Disease. 55(3):1039-1053, 2017
Medline publication type:
- Clinical Trial, Phase I
- Journal Article
- Randomized Controlled Trial
All authors: - Alexander RC, Cebers G, Eketjall S, Ereshefsky L, Goldwater R, Haeberlein SB, Han D, Kugler AR, Maltby J, Olsson T, Rosen L, Russell M, Ye N
|
|
|
2.
|
Phase I trial of dasatinib and ixabepilone in patients with solid tumors. MedStar authors:
- Herbolsheimer, Pia M
- Jelinek, James S
- Kapoor, R
- Perry, David J
- Smith, Karen L
- Swain, Sandra M
- Verma, Nitin
- Veytsman, Irina
Citation: - Investigational New Drugs. 31(1):92-8, 2013 Feb.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase I
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Herbolsheimer P, Jelinek J, Kapoor R, Perry D, Smith KL, Swain SM, Verma N, Veytsman I
|
|
|
3.
|
Single-dose T3 administration: kinetics and effects on biochemical and physiological parameters. MedStar authors:
- Burman, Kenneth D
- Jonklaas, Jacqueline
- Wang, Hong
Citation: - Therapeutic Drug Monitoring. 37(1):110-8, 2015 Feb.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Medline publication type:
- Clinical Trial, Phase I
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Burman KD, Jonklaas J, Latham KR, Wang H
|
|
|
4.
|
Phase I trial of a new schedule of romidepsin in patients with advanced cancers. MedStar authors:
Citation: - Clinical Cancer Research. 19(16):4499-507, 2013 Aug 15.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/General Internal Medicine
Medline publication type:
- Clinical Trial, Phase I
- Journal Article
- Research Support, N.I.H., Intramural
- Research Support, Non-U.S. Gov't
All authors: - Amiri-Kordestani L, Bates SE, Draper D, Figg WD, Fojo T, Frye R, Ghafourian K, Luchenko V, Peer CJ, Piekarz RL, Reynolds J, Skarulis M, Venzon D, Woo S, Wright J
|
|
|
5.
|
Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer. MedStar authors:
Year: 2014
Citation: - Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. 9(1):121-5, 2014 Jan.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Adams JW, Berger MS, Chiappori A, Edelman MJ, Haura EB, Malik S, Northfelt DW, Rosen P, Van Echo DA, Williams C
|
